Myriad Genetics Inc reports results for the quarter ended in December - Earnings Summary

Myriad Genetics

27/02/2024 23:39

* Myriad Genetics Inc  MYGN.OQ  reported quarterly adjusted
earnings of 4 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -12 cents.  The mean expectation of
twelve analysts for the quarter was for earnings of one cent per
share. Wall Street expected results to range from zero cents
to 2 cents per share.
    * Revenue rose 10.6% to $196.60 million from a year ago;
analysts
expected $194.78 million. 
    * Myriad Genetics Inc's reported EPS for the quarter was a
loss
of 36 cents​.
    * The company reported a quarterly loss of $31.2 million.
    * Myriad Genetics Inc shares had risen by 19.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 10.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 5
"hold" and 3 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Myriad Genetics
Inc is $23.00 
This summary was machine generated from LSEG data February 27 at
11:38 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.01           0.04           Beat
 Sep. 30 2023      -0.08          -0.03          Beat
 Jun. 30 2023      -0.08          -0.08          Met
 Mar. 31 2023      -0.19          -0.21          Missed